Clinical Trial Update: Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial (TOPAZ) evaluating topical dermaprazole for radiation dermatitis in breast cancer patients was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Radiation Dermatitis

Drugs mentioned

• Dermaprazole (dermaprazole)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Radiation Dermatitis, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-02-17